1.A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants
Abdoulreza ESTEGHAMATI ; Shirin SAYYAHFAR ; Hossein GHAEMI ; Mohammadamin JOULANI ; Yousef MORADI ; Atefeh TALEBI
Clinical and Experimental Vaccine Research 2021;10(1):47-51
Purpose:
The aim of this study was to compare the hepatitis B surface antibody (HBs Ab) titer 1 month after the 4th dose of hepatitis B vaccine administration on the large and appropriate for gestational age infants.
Materials and Methods:
This cross-sectional study was conducted on 7-month-old cases (n=132) divided into two groups of 2–4 kg (group 1: appropriate for gestational age, 63 cases) and >4 kg (group 2: large for gestational age, 69 cases), whom were vaccinated with a fourdose schedule of hepatitis B vaccine in 2016, Tehran, Iran.
Results:
Mean birth weight of the groups was 2.98±0.528 and 4.19±0.190 kg, respectively.Hepatitis B surface antigen and hepatitis B core antibody were negative in all cases. HBs Ab level in group 1 and 2 was 13,701.00±11,744.439 and 8,997.15±2,827.191, respectively (95% confidence interval of difference, -7,607.44 to -1,800.25). There was a significant difference between the two groups in antibody titration and antibody logarithm level (p=0.002, p=0.0001).
Conclusion
Birth weight may affect the response to the hepatitis B virus vaccine administration.
2.Effects of aromatherapy with Rosa damascena on nulliparous women's pain and anxiety of labor during first stage of labor.
Sepideh HAMDAMIAN ; Soheila NAZARPOUR ; Masoumeh SIMBAR ; Sepideh HAJIAN ; Faraz MOJAB ; Atefeh TALEBI
Journal of Integrative Medicine 2018;16(2):120-125
BACKGROUNDReducing labor pain and anxiety is one of the most important goals of maternity care.
OBJECTIVEThis study aimed to assess the effects of aromatherapy with Rosa damascena on pain and anxiety in the first stage of labor among nulliparous women.
DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONSThis was a randomized clinical trial of 110 nulliparous women. The eligible participants were randomly assigned to two groups of aromatherapy and control in an Iranian maternity hospital. The participants received 0.08 mL of Rosa damascena essence in the aromatherapy group and 0.08 mL of normal saline in the control group, every 30 min. Pain was measured 3 times, once each at three stages of cervical dilation (4-5, 6-7, and 8-10 cm). Anxiety was measured twice, once each at two stages of cervical dilation (4-7 and 8-10 cm). The tools for data collection were the Spielberger anxiety questionnaire, numerical pain rating scale, demographic and obstetric questionnaire, and an observational checklist. Data analyses included the t-test, Mann-Whitney U test and Chi-square test.
MAIN OUTCOME MEASURESSeverity of labor pain and severity of anxiety were used as primary outcome measures. Labor and delivery characteristics (including number of contractions, duration of contractions in second stage, Bishop score, augmentation by oxytocin, Apgar score, and mode of delivery), demographic characteristics, and fertility information were used as secondary outcome measures.
RESULTSPain severity in the group receiving aromatherapy with R. damascena was significantly lower than in the control group after treatment at each pain assessment (cervical dilation of 4-5, 6-7, and 8-10 cm; P < 0.05). Anxiety levels were also significantly lower in the treatment group than in the control group after treatment at each time of measurement (cervical dilation of 4-7 and 8-10 cm; P < 0.05).
CONCLUSIONAromatherapy with R. damascena reduced the severity of pain and anxiety in the first stage of labor. Aromatherapy with R. damascena is a convenient and effective method for pain and anxiety reduction during the first stage of labor.
TRIAL REGISTRATIONIranian Registry of Clinical Trial: IRCT201306258801N3.